Rights and permissions
About this article
Cite this article
Chimeric monoclonal antibody G250: capacity to modulate advanced renal cancer. Inpharma Wkly. 1440, 8 (2004). https://doi.org/10.2165/00128413-200414400-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414400-00024